Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Τίτλος | Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. |
Publication Type | Journal Article |
Year of Publication | 2013 |
Authors | Anastasilakis, A. D., Polyzos S. A., Gkiomisi A., Bisbinas I., Gerou S., & Makras P. |
Journal | J Clin Endocrinol Metab |
Volume | 98 |
Issue | 8 |
Pagination | 3206-12 |
Date Published | 2013 Aug |
ISSN | 1945-7197 |
Λέξεις κλειδιά | Aged, Antibodies, Monoclonal, Humanized, Bone Density, Bone Density Conservation Agents, Bone Morphogenetic Proteins, Collagen Type I, Denosumab, Diphosphonates, Female, Genetic Markers, Humans, Imidazoles, Intercellular Signaling Peptides and Proteins, Middle Aged, Osteoprotegerin, Peptide Fragments, Peptides, Postmenopause, Procollagen, RANK Ligand, Zoledronic Acid |
Abstract | CONTEXT: Decreased bone formation due to a coupling effect limits bone mass increases after antiresorptive treatment. |
DOI | 10.1210/jc.2013-1402 |
Alternate Journal | J. Clin. Endocrinol. Metab. |
PubMed ID | 23788684 |